The Patent Finder

Topigen Pharmaceutique Inc.

Also on record
Records under this name other than patents Topigen Pharmaceutique Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Topigen Pharmaceutique Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,745,420Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
Formerly held
Lapsed on the fee record
Ended Jun 29, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 29, 2022USPTO record
US 6,822,087Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
Formerly held
Term ended
Term ended Jun 29, 2021 · USPTO record
Term endedTerm ended Jun 29, 2021USPTO record
US 7,629,324Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
Term ended
Term ended Oct 31, 2020 · USPTO record
Term endedTerm ended Oct 31, 2020USPTO record
US 7,825,236Oligonucleotide compositions and methods for treating disease including inflammatory conditions
Lapsed on the fee record
Ended Nov 2, 2018 · USPTO record
Lapsed on the fee recordEnded Nov 2, 2018USPTO record
US 7,579,455Oligonucleotide compositions and methods for treating disease including inflammatory conditions
Lapsed on the fee record
Ended Aug 25, 2017 · USPTO record
Lapsed on the fee recordEnded Aug 25, 2017USPTO record
US 8,173,796Oligonucleotide compositions and methods for treating disease including inflammatory conditions
Lapsed on the fee record
Ended May 8, 2016 · USPTO record
Lapsed on the fee recordEnded May 8, 2016USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited